 | CNE | Name: | (3S)-5-[(2-CHLORO-6-FLUOROBENZYL)SULFANYL]-3-{[N-({2-ETHOXY-5-[(1E)-3-METHOXY-3-OXOPROP-1-ENYL]PHENYL}ACETYL)-D-VALYL]AMINO}-4-OXOPENTANOIC ACID | Formula: | C31 H36 Cl F N2 O8 S | SMILES: | Clc1cccc(F)c1CSCC(=O)C(NC(=O)C(NC(=O)Cc2cc(C=CC(=O)OC)ccc2OCC)C(C)C)CC(=O)O | InChi: | InChI=1S/C31H36ClFN2O8S/c1-5-43-26-11-9-19(10-12-29(40)42-4)13-20(26)14-27(37)35-30(18(2)3)31(41)34-24(15-28(38)39)25(36)17-44-16-21-22(32)7-6-8-23(21)33/h6-13,18,24,30H,5,14-17H2,1-4H3,(H,34,41)(H,35,37)(H,38,39)/b12-10+/t24-,30-/m0/s1 | Definition date: | 2003-11-24 | Last modified: | 2024-09-27 | Identifier: | (3S)-5-[(2-chloro-6-fluorobenzyl)sulfanyl]-3-{[N-({2-ethoxy-5-[(1E)-3-methoxy-3-oxoprop-1-en-1-yl]phenyl}acetyl)-L-valyl]amino}-4-oxopentanoic acid |
|
 | MDL | Name: | [DEHYDROXY-N-METHYL-TYROSYL-PROLINYL]-[4,4,5,5,5-PENTAFLUORO-3-OXY-1-[3-INDOLYL]-PENT-2-YL]AMINE | Formula: | C28 H29 F5 N4 O3 | SMILES: | O=C(NC(C(=O)C(F)(F)C(F)(F)F)Cc2c1ccccc1nc2)C4N(C(=O)C(NC)Cc3ccccc3)CCC4 | InChi: | InChI=1S/C28H29F5N4O3/c1-34-22(14-17-8-3-2-4-9-17)26(40)37-13-7-12-23(37)25(39)36-21(24(38)27(29,30)28(31,32)33)15-18-16-35-20-11-6-5-10-19(18)20/h2-6,8-11,16,21-23,34-35H,7,12-15H2,1H3,(H,36,39)/t21-,22+,23-/m0/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-methyl-D-phenylalanyl-N-[(2S)-4,4,5,5,5-pentafluoro-1-(1H-indol-3-yl)-3-oxopentan-2-yl]-L-prolinamide |
|
 | MDP | Name: | N-carboxyl-N-methyl-beta-muramic acid | Formula: | C11 H19 N O9 | SMILES: | O=C(O)C(OC1C(O)C(OC(O)C1N(C(=O)O)C)CO)C | InChi: | InChI=1S/C11H19NO9/c1-4(9(15)16)20-8-6(12(2)11(18)19)10(17)21-5(3-13)7(8)14/h4-8,10,13-14,17H,3H2,1-2H3,(H,15,16)(H,18,19)/t4-,5-,6-,7-,8-,10-/m1/s1 | Synonyms: | N-CARBOXY-N-METHYL-MURAMIC ACID | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 3-O-[(1R)-1-carboxyethyl]-2-[carboxy(methyl)amino]-2-deoxy-alpha-D-glucopyranose |
|
 | MER | Name: | (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-d
ihydro-1H-pyrrole-2-carboxylic acid | Formula: | C17 H27 N3 O5 S | SMILES: | O=C(O)C2=C(SC1CC(C(=O)N(C)C)NC1)C(C(N2)C(C=O)C(O)C)C | InChi: | InChI=1S/C17H27N3O5S/c1-8-13(11(7-21)9(2)22)19-14(17(24)25)15(8)26-10-5-12(18-6-10)16(23)20(3)4/h7-13,18-19,22H,5-6H2,1-4H3,(H,24,25)/t8-,9-,10+,11-,12+,13-/m1/s1 | Synonyms: | Meropenem, bound form | Definition date: | 2001-02-17 | Last modified: | 2024-09-27 | Identifier: | (4R,5S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-5-[(2S,3R)-3-hydroxy-1-oxobutan-2-yl]-4-methyl-4,5-dihydro-1H-pyrrole-2-carboxylic acid |
|
 | CQ6 | Name: | 7-ethylsulfonyl-N-(oxan-4-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-amine | Formula: | C14 H22 N4 O3 S | SMILES: | CC[S](=O)(=O)N1CCc2cnc(NC3CCOCC3)nc2C1 | InChi: | InChI=1S/C14H22N4O3S/c1-2-22(19,20)18-6-3-11-9-15-14(17-13(11)10-18)16-12-4-7-21-8-5-12/h9,12H,2-8,10H2,1H3,(H,15,16,17) | Definition date: | 2015-04-13 | Last modified: | 2024-09-27 | Release date: | 2015-05-27 | Identifier: | 7-ethylsulfonyl-N-(oxan-4-yl)-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-2-amine |
|
 | MGG | Name: | 2-(2-CARBOXY-ACETYLAMINO)-5-GUANIDINO-PENTANOIC ACID | Formula: | C9 H17 N4 O5 | SMILES: | O=C(NC(C(=O)O)CCCNC(=[NH2+])N)CC(=O)O | InChi: | InChI=1S/C9H16N4O5/c10-9(11)12-3-1-2-5(8(17)18)13-6(14)4-7(15)16/h5H,1-4H2,(H,13,14)(H,15,16)(H,17,18)(H4,10,11,12)/p+1/t5-/m1/s1 | Synonyms: | D-ARGININE WITH 3-OXO-PROPIONIC ACID MODIFICATION | Definition date: | 1999-08-25 | Last modified: | 2024-09-27 | Identifier: | amino({(4R)-4-carboxy-4-[(carboxyacetyl)amino]butyl}amino)methaniminium |
|
 | CUD | Name: | 3-(4-amino-2-oxopyrimidin-1(2H)-yl)-D-alanine | Formula: | C7 H10 N4 O3 | SMILES: | O=C1N=C(C=CN1CC(C(=O)O)N)N | InChi: | InChI=1S/C7H10N4O3/c8-4(6(12)13)3-11-2-1-5(9)10-7(11)14/h1-2,4H,3,8H2,(H,12,13)(H2,9,10,14)/t4-/m1/s1 | Definition date: | 2008-02-12 | Last modified: | 2024-09-27 | Identifier: | 3-(4-amino-2-oxopyrimidin-1(2H)-yl)-D-alanine |
|
 | CUX | Name: | 2-[[7-[(2~{R},3~{R},4~{S},5~{R})-5-[(~{R})-(4-chlorophenyl)-oxidanyl-methyl]-3,4-bis(oxidanyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanal | Formula: | C19 H19 Cl N4 O5 | SMILES: | O[CH]1[CH](O)[CH](O[CH]1[CH](O)c2ccc(Cl)cc2)n3ccc4c(NCC=O)ncnc34 | InChi: | InChI=1S/C19H19ClN4O5/c20-11-3-1-10(2-4-11)13(26)16-14(27)15(28)19(29-16)24-7-5-12-17(21-6-8-25)22-9-23-18(12)24/h1-5,7-9,13-16,19,26-28H,6H2,(H,21,22,23)/t13-,14+,15-,16-,19-/m1/s1 | Definition date: | 2019-05-16 | Last modified: | 2024-09-27 | Release date: | 2019-06-19 | Identifier: | 2-[[7-[(2~{R},3~{R},4~{S},5~{R})-5-[(~{R})-(4-chlorophenyl)-oxidanyl-methyl]-3,4-bis(oxidanyl)oxolan-2-yl]pyrrolo[2,3-d]pyrimidin-4-yl]amino]ethanal |
|
 | MLU | Name: | N-methyl-D-leucine | Formula: | C7 H15 N O2 | SMILES: | O=C(O)C(NC)CC(C)C | InChi: | InChI=1S/C7H15NO2/c1-5(2)4-6(8-3)7(9)10/h5-6,8H,4H2,1-3H3,(H,9,10)/t6-/m1/s1 | Definition date: | 2010-08-06 | Last modified: | 2024-09-27 | Identifier: | N-methyl-D-leucine |
|
 | MND | Name: | N-methyl-D-asparagine | Formula: | C5 H10 N2 O3 | SMILES: | O=C(NC)CC(N)C(=O)O | InChi: | InChI=1S/C5H10N2O3/c1-7-4(8)2-3(6)5(9)10/h3H,2,6H2,1H3,(H,7,8)(H,9,10)/t3-/m1/s1 | Definition date: | 2008-06-02 | Last modified: | 2024-09-27 | Identifier: | N-methyl-D-asparagine |
|
 | CYC | Name: | PHYCOCYANOBILIN | Formula: | C33 H40 N4 O6 | SMILES: | CC[CH]1[CH](C)C(=O)NC1=Cc2[nH]c(C=C3N=C(C=C4NC(=O)C(=C4C)CC)C(=C3CCC(O)=O)C)c(CCC(O)=O)c2C | InChi: | InChI=1S/C33H40N4O6/c1-7-20-19(6)32(42)37-27(20)14-25-18(5)23(10-12-31(40)41)29(35-25)15-28-22(9-11-30(38)39)17(4)24(34-28)13-26-16(3)21(8-2)33(43)36-26/h13-15,19-20,35H,7-12H2,1-6H3,(H,36,43)(H,37,42)(H,38,39)(H,40,41)/b26-13-,27-14-,28-15-/t19-,20-/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | (3R,4R)-4-ethyl-3-methyl-5-methylenepyrrolidin-2-one |
|
 | MOV | Name: | AMG 510 (bound form) | Formula: | C30 H32 F2 N6 O3 | SMILES: | CC1N(CCN(C1)C(=O)CC)C3=NC(=O)N(c2c(nccc2C)C(C)C)c4c3cc(F)c(n4)c5c(F)cccc5O | InChi: | InChI=1S/C30H32F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h7-11,14,16,18,39H,6,12-13,15H2,1-5H3/t18-/m0/s1 | Synonyms: | 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-4-[(2S)-2-methyl-4-propanoylpiperazin-1-yl]-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]pyrido[2,3-d]pyrimidin-2(1H)-one | Definition date: | 2019-04-10 | Last modified: | 2024-09-27 | Release date: | 2019-11-06 | Identifier: | 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-4-[(2S)-2-methyl-4-propanoylpiperazin-1-yl]-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]pyrido[2,3-d]pyrimidin-2(1H)-one |
|
 | CZ9 | Name: | N-[(dihydroxyboranyl)methyl]-Nalpha-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-tyrosinamide | Formula: | C17 H23 B N4 O7 | SMILES: | O=C(NCB(O)O)C(NC(=O)N1C(=O)C(=O)N(CC)CC1)Cc2ccc(O)cc2 | InChi: | InChI=1S/C17H23BN4O7/c1-2-21-7-8-22(16(26)15(21)25)17(27)20-13(14(24)19-10-18(28)29)9-11-3-5-12(23)6-4-11/h3-6,13,23,28-29H,2,7-10H2,1H3,(H,19,24)(H,20,27)/t13-/m1/s1 | Definition date: | 2010-07-30 | Last modified: | 2024-09-27 | Identifier: | N-[(dihydroxyboranyl)methyl]-Nalpha-[(4-ethyl-2,3-dioxopiperazin-1-yl)carbonyl]-D-tyrosinamide |
|
 | WY2 | Name: | (6,7-DIHYDRO-5H-CYCLOPENTA[D]IMIDAZO[2,1-B]THIAZOL-2-YL]-4,7-DIHYDRO[1,4]THIAZEPINE-3,6-DICARBOXYLIC ACID | Formula: | C15 H13 N3 O4 S2 | SMILES: | O=C(O)C1=NC=C(C(=O)O)C(SC1)c2nc3sc4c(n3c2)CCC4 | InChi: | InChI=1S/C15H13N3O4S2/c19-13(20)7-4-16-9(14(21)22)6-23-12(7)8-5-18-10-2-1-3-11(10)24-15(18)17-8/h4-5,12H,1-3,6H2,(H,19,20)(H,21,22)/t12-/m1/s1 | Definition date: | 2003-08-21 | Last modified: | 2024-09-27 | Identifier: | (7R)-7-(6,7-dihydro-5H-cyclopenta[d]imidazo[2,1-b][1,3]thiazol-2-yl)-2,7-dihydro-1,4-thiazepine-3,6-dicarboxylic acid |
|
 | X2F | Name: | 2-deoxy-2-fluoro-alpha-D-xylopyranose | Formula: | C5 H9 F O4 | SMILES: | FC1C(O)C(O)COC1O | InChi: | InChI=1S/C5H9FO4/c6-3-4(8)2(7)1-10-5(3)9/h2-5,7-9H,1H2/t2-,3-,4+,5+/m1/s1 | Synonyms: | 2-DEOXY-2-FLUORO XYLOPYRANOSE | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | 2-deoxy-2-fluoro-alpha-D-xylopyranose |
|
 | X6E | Name: | 2-ethyl-D-norvaline | Formula: | C7 H15 N O2 | SMILES: | CCCC(N)(CC)C(=O)O | InChi: | InChI=1S/C7H15NO2/c1-3-5-7(8,4-2)6(9)10/h3-5,8H2,1-2H3,(H,9,10)/t7-/m1/s1 | Definition date: | 2023-06-02 | Last modified: | 2024-09-27 | Release date: | 2023-08-16 | Identifier: | 2-ethyl-D-norvaline |
|
 | 8WN | Name: | ~{N}-[2-[4-[4-[(1-methyl-4-oxidanylidene-pyrazolo[3,4-d]pyrimidin-5-yl)methyl]-4-oxidanyl-piperidin-1-yl]carbonylphenyl]phenyl]ethanesulfonamide | Formula: | C27 H30 N6 O5 S | SMILES: | CC[S](=O)(=O)Nc1ccccc1c2ccc(cc2)C(=O)N3CCC(O)(CC3)CN4C=Nc5n(C)ncc5C4=O | InChi: | InChI=1S/C27H30N6O5S/c1-3-39(37,38)30-23-7-5-4-6-21(23)19-8-10-20(11-9-19)25(34)32-14-12-27(36,13-15-32)17-33-18-28-24-22(26(33)35)16-29-31(24)2/h4-11,16,18,30,36H,3,12-15,17H2,1-2H3 | Definition date: | 2017-03-17 | Last modified: | 2024-09-27 | Release date: | 2017-10-18 | Identifier: | ~{N}-[2-[4-[4-[(1-methyl-4-oxidanylidene-pyrazolo[3,4-d]pyrimidin-5-yl)methyl]-4-oxidanyl-piperidin-1-yl]carbonylphenyl]phenyl]ethanesulfonamide |
|
 | 8Y0 | Name: | (E)-N-[(3E)-2-oxo-16-(8-{6-[(trifluoroacetyl)amino]hexanoyl}-8,9-dihydro-1H-dibenzo[b,f][1,2,3]triazolo[4,5-d]azocin-1-yl)hexadec-3-en-1-ylidene]glycine | Formula: | C41 H51 F3 N6 O5 | SMILES: | OC(=O)CN=CC(=O)C=CCCCCCCCCCCCCn1nnc2c3ccccc3N(Cc4ccccc4c12)C(=O)CCCCCNC(=O)C(F)(F)F | InChi: | InChI=1S/C41H51F3N6O5/c42-41(43,44)40(55)46-26-18-11-13-25-36(52)49-30-31-20-14-15-22-33(31)39-38(34-23-16-17-24-35(34)49)47-48-50(39)27-19-10-8-6-4-2-1-3-5-7-9-12-21-32(51)28-45-29-37(53)54/h12,14-17,20-24,28H,1-11,13,18-19,25-27,29-30H2,(H,46,55)(H,53,54)/b21-12+,45-28+ | Definition date: | 2017-11-06 | Last modified: | 2024-09-27 | Release date: | 2017-11-22 |
|
 | SUU | Name: | (E)-3-(3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl)-2-cyanoacrylamide bound form | Formula: | C16 H13 N5 O | SMILES: | NC(=O)C(C#N)Cc1cccc(c1)c1ncnc2[NH]ccc12 | InChi: | InChI=1S/C16H13N5O/c17-8-12(15(18)22)7-10-2-1-3-11(6-10)14-13-4-5-19-16(13)21-9-20-14/h1-6,9,12H,7H2,(H2,18,22)(H,19,20,21)/t12-/m0/s1 | Definition date: | 2022-07-11 | Last modified: | 2024-09-27 | Release date: | 2022-08-31 | Identifier: | (2S)-2-cyano-3-[(3M)-3-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)phenyl]propanamide |
|
 | D0C | Name: | 4-chloro-D-phenylalanine | Formula: | C9 H10 Cl N O2 | SMILES: | NC(Cc1ccc(cc1)Cl)C(=O)O | InChi: | InChI=1S/C9H10ClNO2/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,8H,5,11H2,(H,12,13)/t8-/m1/s1 | Definition date: | 2020-10-29 | Last modified: | 2024-09-27 | Release date: | 2021-11-17 | Identifier: | 4-chloro-D-phenylalanine |
|
 | D11 | Name: | D-PHOSPHOTHREONINE | Formula: | C4 H10 N O6 P | SMILES: | O=P(O)(O)OC(C(N)C(=O)O)C | InChi: | InChI=1S/C4H10NO6P/c1-2(3(5)4(6)7)11-12(8,9)10/h2-3H,5H2,1H3,(H,6,7)(H2,8,9,10)/t2-,3+/m0/s1 | Synonyms: | O-PHOSPHONO-D-THREONINE | Definition date: | 2006-11-15 | Last modified: | 2024-09-27 | Identifier: | O-phosphono-D-threonine |
|
 | SWW | Name: | (2~{S})-2-azanyl-3-(2-hydroxyethylsulfanyl)propanoic acid | Formula: | C5 H11 N O3 S | SMILES: | N[CH](CSCCO)C(O)=O | InChi: | InChI=1S/C5H11NO3S/c6-4(5(8)9)3-10-2-1-7/h4,7H,1-3,6H2,(H,8,9)/t4-/m1/s1 | Synonyms: | S-(2-hydroxyethyl)-D-cysteine | Definition date: | 2020-12-02 | Last modified: | 2024-09-27 | Release date: | 2022-01-12 | Identifier: | (2~{S})-2-azanyl-3-(2-hydroxyethylsulfanyl)propanoic acid |
|
 | T17 | Name: | {[4-(1-{3-[(3aS,4R,7R,9R,10R,11R,13R,15R,15aR)-10-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,8,14-tetraoxododecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-1(4H)-yl]propyl}-1H-1,2,3-triazol-4-yl)butanoyl]amino}acetic acid | Formula: | C42 H68 N6 O13 | SMILES: | O=C(O)CNC(=O)CCCc1nnn(c1)CCCN3C(=O)OC4(C(OC(=O)C(C(=O)C(C(OC2OC(C)CC(N(C)C)C2O)C(OC)(C)CC(C(=O)C(C)C34)C)C)C)CC)C | InChi: | InChI=1S/C42H68N6O13/c1-12-30-42(8)36(48(40(56)61-42)18-14-17-47-22-28(44-45-47)15-13-16-31(49)43-21-32(50)51)25(4)33(52)23(2)20-41(7,57-11)37(26(5)34(53)27(6)38(55)59-30)60-39-35(54)29(46(9)10)19-24(3)58-39/h22-27,29-30,35-37,39,54H,12-21H2,1-11H3,(H,43,49)(H,50,51)/t23-,24-,25+,26+,27-,29+,30-,35-,36-,37-,39+,41-,42-/m1/s1 | Definition date: | 2014-05-10 | Last modified: | 2024-09-27 | Release date: | 2014-10-01 | Identifier: | {[4-(1-{3-[(3aS,4R,7R,9R,10R,11R,13R,15R,15aR)-10-{[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy}-4-ethyl-11-methoxy-3a,7,9,11,13,15-hexamethyl-2,6,8,14-tetraoxododecahydro-2H-oxacyclotetradecino[4,3-d][1,3]oxazol-1(4H)-yl]propyl}-1H-1,2,3-triazol-4-yl)butanoyl]amino}acetic acid (non-preferred name) |
|
 | T1O | Name: | 5-[(3aS,4R,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-(2-oxopropyl)pentanamide | Formula: | C13 H21 N3 O3 S | SMILES: | O=C2NC1C(SCC1N2)CCCCC(=O)NCC(=O)C | InChi: | InChI=1S/C13H21N3O3S/c1-8(17)6-14-11(18)5-3-2-4-10-12-9(7-20-10)15-13(19)16-12/h9-10,12H,2-7H2,1H3,(H,14,18)(H2,15,16,19)/t9-,10+,12-/m0/s1 | Definition date: | 2017-07-08 | Last modified: | 2024-09-27 | Release date: | 2018-07-11 | Identifier: | 5-[(3aS,4R,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl]-N-(2-oxopropyl)pentanamide |
|
 | T29 | Name: | TRI166 (BIFUNCTIONAL BORONATE INHIBITOR) | Formula: | C22 H34 B N5 O5 S | SMILES: | O=C(NC(B(O)O)CCCSC(=[N@H])N)C2N(C(=O)C(NC(=O)CC)Cc1ccccc1)CCC2 | InChi: | InChI=1S/C22H34BN5O5S/c1-2-19(29)26-16(14-15-8-4-3-5-9-15)21(31)28-12-6-10-17(28)20(30)27-18(23(32)33)11-7-13-34-22(24)25/h3-5,8-9,16-18,32-33H,2,6-7,10-14H2,1H3,(H3,24,25)(H,26,29)(H,27,30)/t16-,17+,18+/m1/s1 | Definition date: | 1999-07-08 | Last modified: | 2024-09-27 | Identifier: | N-propanoyl-D-phenylalanyl-N-[(1R)-4-(carbamimidoylsulfanyl)-1-(dihydroxyboranyl)butyl]-L-prolinamide |
|